As of 2025-03-25, the EV/EBITDA ratio of Valeo Pharma Inc (VPH.TO) is -5.61. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VPH.TO's latest enterprise value is 67.40 mil CAD. VPH.TO's TTM EBITDA according to its financial statements is -12.02 mil CAD. Dividing these 2 quantities gives us the above VPH.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |